Literature DB >> 1892746

Membrane-interactive lipids as experimental anticancer drugs.

W E Berdel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1892746      PMCID： PMC1977494          DOI： 10.1038/bjc.1991.277

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  47 in total

1.  Selective destruction of human leukemic cells by alkyl-lysophospholipids.

Authors:  R Andreesen; M Modolell; H U Weltzien; H Eibl; H H Common; G W Löhr; P G Munder
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

2.  The influence of alkyl-lysophospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3-Lewis lung carcinoma.

Authors:  W E Berdel; W R Bausert; H U Weltzien; M L Modolell; K H Widmann; P G Munder
Journal:  Eur J Cancer       Date:  1980-09       Impact factor: 9.162

3.  Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.

Authors:  G W Bazill; T M Dexter
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

4.  Novel membrane-interactive ether lipid analogs that inhibit infectious HIV-1 production and induce defective virus formation.

Authors:  L S Kucera; N Iyer; E Leake; A Raben; E J Modest; L W Daniel; C Piantadosi
Journal:  AIDS Res Hum Retroviruses       Date:  1990-04       Impact factor: 2.205

5.  Increase of transferrin binding induced by an alkyl-lysophospholipid in breast cancer cells.

Authors:  H Kosano; O Takatani
Journal:  J Lipid Mediat       Date:  1990 Mar-Apr

6.  Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.

Authors:  L F Verdonck; E O Witteveen; H G van Heugten; E Rozemuller; G Rijksen
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

7.  Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.

Authors:  M J Seewald; R A Olsen; I Sehgal; D C Melder; E J Modest; G Powis
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

8.  Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.

Authors:  H Kosano; Y Yasutomo; N Kugai; N Nagata; H Inagaki; S Tanaka; O Takatani
Journal:  Cancer Res       Date:  1990-06-01       Impact factor: 12.701

9.  Elevation of leukemic cell intracellular calcium by the ether lipid SRI 62-834.

Authors:  C M Lazenby; M G Thompson; J A Hickman
Journal:  Cancer Res       Date:  1990-06-01       Impact factor: 12.701

10.  Destruction of human solid tumors by alkyl lysophospholipids.

Authors:  M H Runge; R Andreesen; A Pfleiderer; P G Munder
Journal:  J Natl Cancer Inst       Date:  1980-06       Impact factor: 13.506
View more
  17 in total

1.  Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.

Authors:  G W Small; J C Strum; L W Daniel
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

2.  The ether lipid ET-18-OCH3 increases cytosolic Ca2+ concentrations in Madin Darby canine kidney cells.

Authors:  C R Jan; S N Wu; C J Tseng
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

3.  New drugs for BNCT: an experimental approach.

Authors:  L Weissfloch; M Bremer; P Lemmen; T Probst; M Wagner; M Peller; T Auberger; R Senekowitsch-Schmidtke; K Tempel; M Molls
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

4.  1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells.

Authors:  X Zhou; X Lu; C Richard; W Xiong; D W Litchfield; R Bittman; G Arthur
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

5.  Cellular uptake and retention measurements of alkylphosphocholines in the SK-BR-3 breast cancer and Molt-4 leukemia cell line using capillary gas chromatography.

Authors:  V Brochez; D Van Heuverswyn; J A Diniz; C R De Potter; E G Van den Eeckhout
Journal:  Lipids       Date:  1999-05       Impact factor: 1.880

Review 6.  Emerging drug treatments for solid tumours.

Authors:  J H Schellens; L C Pronk; J Verweij
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

7.  Superoxide production by macrophages stimulated in vivo with synthetic ether lipids.

Authors:  B M Schreiber; M D Layne; E J Modest
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

8.  Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug.

Authors:  F Javier Pérez-Victoria; Santiago Castanys; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  Relationship of cell survival, drug dose, and drug uptake after 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine treatment.

Authors:  K Fujiwara; L W Daniel; E J Modest; C A Wallen
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomas in vivo and in vitro; use of liposomes.

Authors:  I Fichtner; R Zeisig; H Naundorf; S Jungmann; D Arndt; G Asongwe; J A Double; M C Bibby
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.